IntroductionIBD is a chronic systemic inflammatory disease that predominantly involves the gastrointestinal tract. At the same time, it exerts numerous cardiovascular manifestations, like atherosclerotic cardiovascular disease and thromboembolic events, due to a hypercoagulable state. Although the disease mechanism is unclear, factors responsible, like the disruption of the normal coagulation cascade, hyperhomocysteinemia, abnormalities in platelet-endothelial cell interactions, and increased fibrinolysis, are implicated.